BioSpace News Archive

Pharm Country

Inspirna to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

Inspirna, Inc. announced today that CEO Masoud Tavazoie, M.D., Ph.D., will present at the Piper Sandler 33rd Annual Virtual Healthcare Conference at 10:00 A.M. EST on November 22, 2021.

November 22, 2021
·
1 min read
Genetown

PerkinElmer Launches Cloud Based Solution to Enable Remote Lab Management

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its PKeye™ Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows in real-time.

November 22, 2021
·
2 min read
Business

Tenaya Therapeutics Announces the Addition of Dr. June Lee to its Board of Directors

Tenaya Therapeutics, Inc. today announced changes to its Board of Directors including the addition of June Lee, M.D., and the transition of JJ Kang, Ph.D., who will be stepping down after five years of service.

November 22, 2021
·
5 min read
Biotech Beach

Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference

Arcturus Therapeutics Holdings Inc. today announced that members of the Company’s management team will be participating in the Piper Sandler’s 33rd Annual Virtual Healthcare Conference and investor meetings November 30 and December 2, 2021.

November 22, 2021
·
2 min read
FDA

REGENXBIO Announces Orphan Drug Designation Granted to RGX-202, a Novel Gene Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy

Potential one-time gene therapy for the treatment of Duchenne, includes a novel, optimized microdystrophin transgene and REGENXBIO’s proprietary NAV ® AAV8 vector Commercial-scale cGMP material to be used in clinical development Company on track to submit IND by end of 2021.

November 22, 2021
·
6 min read
Genetown

Korro Bio to Present at the Evercore ISI 4th Annual HealthCONx Conference and the Piper Sandler 33rd Annual Virtual Healthcare Conference

Korro Bio to Present at the Evercore ISI 4th Annual HealthCONx Conference and the Piper Sandler 33rd Annual Virtual Healthcare Conference.

November 22, 2021
·
1 min read
Drug Development

BeiGene Initiates First-in-Human Phase 1 Clinical Trial of Investigational TYK2 Inhibitor BGB-23339

BeiGene today announced that the first patient has been dosed in a Phase 1 clinical trial of BGB-23339, a potent, allosteric investigational tyrosine kinase 2 (TYK2) inhibitor internally developed by BeiGene scientists.

November 22, 2021
·
5 min read
Drug Development

Intellia Therapeutics Announces Expansion of Ongoing Phase 1 Study of NTLA-2001 to Include Adults with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

Intellia Therapeutics, Inc. announced today that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has approved a protocol amendment for the Company’s ongoing Phase 1 study of NTLA-2001 to include patients with ATTR amyloidosis with cardiomyopathy (ATTR-CM).

November 22, 2021
·
8 min read
Business

Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration with Regeneron to Discover and Develop Gene Therapies for Hearing Loss

Decibel Therapeutics today announced that Regeneron has extended the research term of its collaboration with the Company to discover and develop gene therapies for hearing loss.

November 22, 2021
·
6 min read
Pharm Country

Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference

Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1, 2021 at 1:50 p.m. ET.

November 22, 2021
·
1 min read